| Literature DB >> 33801867 |
Vetriselvi Sampath1, Dong Heon Baek2, Sureshkumar Shanmugam1, In Ho Kim1.
Abstract
This experiment was performed to examine the hypothesis that blood plasma (BP) with yeast (Entities:
Keywords: Sacchromyces cerevisiae; blood plasma; growth performance; weaning pigs
Year: 2021 PMID: 33801867 PMCID: PMC8000955 DOI: 10.3390/ani11030759
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Composition of weaning pig diets (as fed-basis).
| Item | Phase 1 (0–7 d) | Phase 2 (8–21) | Phase 3 | ||||
|---|---|---|---|---|---|---|---|
| TRT1 | TRT2 | TRT3 | TRT1 | TRT2 | TRT3 | ||
| Ingredients, % | |||||||
| Corn | 39.22 | 36.31 | 33.29 | 52.48 | 50.98 | 49.51 | 59.29 |
| Soybean meal | 16.42 | 18.92 | 21.45 | 16.60 | 17.87 | 19.12 | 22.46 |
| Fermented soybean meal | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 3.00 |
| SDPP | 6.00 | 3.00 | - | 3.00 | 1.50 | - | - |
| Yeast | - | 3.00 | 6.00 | - | 1.50 | 3.00 | - |
| Tallow | 2.49 | 2.92 | 3.39 | 2.53 | 2.76 | 2.98 | 2.49 |
| Lactose | 13.46 | 13.46 | 13.46 | 7.78 | 7.78 | 7.78 | 3.18 |
| Sugar | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Whey protein | 11.00 | 11.00 | 11.00 | 7.00 | 7.00 | 7.00 | 3.00 |
| Monocalcium phosphate | 0.90 | 0.86 | 0.82 | 1.08 | 1.06 | 1.04 | 1.14 |
| Limestone | 1.17 | 1.16 | 1.18 | 1.20 | 1.20 | 1.20 | 1.22 |
| Salt | 0.20 | 0.20 | 0.20 | 0.10 | 0.10 | 0.10 | 0.10 |
| Methionine (99%) | 0.22 | 0.21 | 0.21 | 0.15 | 0.15 | 0.15 | 0.08 |
| Lysine | 0.49 | 0.53 | 0.57 | 0.65 | 0.67 | 0.69 | 0.61 |
| Mineral mix 1 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Vitamin mix 2 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Choline (25%) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
| |||||||
| Crude protein, % | 20.00 | 20.00 | 20.00 | 18.00 | 18.00 | 18.00 | 18.00 |
| Ca, % | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| P, % | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 |
| Lys, % | 1.60 | 1.60 | 1.60 | 1.50 | 1.50 | 1.50 | 1.40 |
| Met, % | 0.48 | 0.48 | 0.48 | 0.40 | 0.40 | 0.40 | 0.35 |
| Metabolic Energy, kcal/kg | 3450 | 3450 | 3450 | 3400 | 3400 | 3400 | 3350 |
| FAT, % | 4.18 | 4.55 | 4.94 | 4.65 | 4.84 | 5.03 | 4.89 |
| Lactose, % | 20.00 | 20.00 | 20.00 | 12.00 | 12.00 | 12.00 | 5.00 |
1 Provided per kg diet: Fe, 100 mg as ferrous sulfate; Cu, 17 mg as copper sulfate; Mn, 17 mg as manganese oxide; Zn, 100 mg as zinc oxide; I, 0.5 mg as potassium iodide; and Se, 0.3 mg as sodium selenite. 2 Provided per kilograms of diet: vitamin A, 10,800 IU; vitamin D3, 4000 IU; vitamin E, 40 IU; vitamin K3, 4 mg; vitamin B1, 6 mg; vitamin B2, 12 mg; vitamin B6, 6 mg; vitamin B12, 0.05 mg; biotin, 0.2 mg; folic acid, 2 mg; niacin, 50 mg; D-calcium pantothenate, 25 mg.
Effect of blood plasma and yeast supplementation on the growth performance of weaning pigs 1.
| Items | TRT1 1 | TRT2 1 | TRT3 1 | SEM 2 | |
|---|---|---|---|---|---|
| Body weight, kg | |||||
| Initial | 6.61 | 6.61 | 6.61 | 0.002 | 1.000 |
| Phase 1 | 8.24 | 8.53 | 7.95 | 0.42 | 0.107. |
| Phase 2 | 13.98 | 14.27 | 12.35 | 0.23 | 0.043 |
| Phase 3 | 24.89 | 27.14 | 23.70 | 0.38 | 0.032 |
| Phase 1 (0–7 days) | |||||
| ADG, g | 197 | 206 | 193 | 0.433 | 0.047 |
| ADFI, g | 214 | 219 | 199 | 10 | 0.913 |
| FCR | 1.112 | 1.120 | 1.109 | 0.015 | 0.321 |
| Phase 2 (8–21 days) | |||||
| ADG, g | 321 | 358 | 314 | 0.14 | 0.025 |
| ADFI, g | 433 | 415 | 436 | 15 | 0.741 |
| FCR | 1.380 | 1.363 | 1.399 | 0.022 | 0.428 |
| Phase 3 (22–42 days) | |||||
| ADG, g | 566 | 579 | 541 | 0.16 | 0.018 |
| ADFI, g | 791 | 790 | 785 | 17 | 0.583 |
| FCR | 1.467 | 1.479 | 1.491 | 0.015 | 0.169 |
| Overall | |||||
| ADG, g | 437 | 444 | 407 | 0.9 | 0.012 |
| ADFI, g | 579 | 577 | 564 | 10 | 0.844 |
| FCR | 1.424 | 1.417 | 1.437 | 0.013 | 0.347 |
1 Abbreviation: Phase 1: TRT1, 6% blood plasma (BP); TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeas.t Phase 3: TRT1; TRT2; TRT3, Basal diet. (CON). 2 Standard error of means.
Effect of blood plasma and yeast supplementation on nutrient digestibility of weaning pigs 1.
| Items, % | TRT1 1 | TRT2 1 | TRT3 1 | SEM 2 | |
|---|---|---|---|---|---|
| Dry matter | 83.97 | 85.45 | 82.95 | 0.53 | 0.012 |
| Nitrogen | 81.59 b | 82.93 a | 80.67 ab | 0.66 | 0.040 |
| Energy | 80.72 | 82.73 | 81.01 | 0.64 | 0.077 |
1 Abbreviation: Phase 1: TRT1, 6% BP; TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeast. Phase 3: TRT1; TRT2; TRT3, Basal diet. (CON). 2 Standard error of means. a,b Means in the same row with different superscript differ significantly (p < 0.05).
Effect of blood plasma and yeast supplementation on the fecal microbial profile of weaning pigs 1.
| Items, log10cfu/g | TRT1 1 | TRT2 1 | TRT 1 | SEM 2 | |
|---|---|---|---|---|---|
| Phase 1 (0–7 days) | |||||
|
| 7.35 | 7.40 | 7.37 | 0.04 | 0.079 |
|
| 6.02 | 5.42 | 5.03 | 0.09 | 0.210 |
| Phase 2 (8–21 days) | |||||
|
| 7.50 | 7.58 | 7.44 | 0.29 | 0.061 |
|
| 6.76 | 5.68 | 5.14 | 0.31 | 0.275 |
| Phase 3 (22–42 days) | |||||
|
| 7.61 | 7.69 | 7.52 | 0.05 | 0.021 |
|
| 7.14 | 6.19 | 5.30 | 0.07 | 0.485 |
1 Abbreviation: Phase 1: TRT1, 6% BP; TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeast. Phase 3: TRT1; TRT2; TRT3, Basal diet (CON). 2 Standard error of means.
Effect of blood plasma and yeast supplementation on the gas emission of weaning pigs 1.
| Items, ppm | TRT1 1 | TRT2 1 | TRT3 1 | SEM 2 | |
|---|---|---|---|---|---|
| Phase 1 (0–7 days) | |||||
| NH3 | 10.0 | 9.3 | 8.9 | 0.2 | 0.572 |
| H2S | 3.5 | 2.7 | 2.8.0 | 0.5 | 0.145 |
| Acetaldehyde | 2.5 | 2.8 | 2.4 | 0.3 | 0.617 |
| CO2 | 1375 | 1325 | 1400 | 248 | 0.837 |
| Acetic acid | 2.3 | 2.0 | 1.7 | 0.4 | 0.334 |
| Propionic acid | 1.7 | 1.5 | 1.2 | 0.4 | 0.101 |
| Phase 2 (8–21 days) | |||||
| NH3 | 10.8 | 9.8 | 11.4 | 0.1 | 0.074 |
| H2S | 1.7 | 1.5 | 2.3 | 0.5 | 0.069 |
| Acetaldehyde | 2.4 | 2.3 | 2.9 | 0.5 | 0.694 |
| CO2 | 1200 | 1375 | 1275 | 272 | 0.995 |
| Acetic acid | 1.5 | 2.0 | 1.9 | 0.6 | 0.743 |
| Propionic acid | 2.4 | 1.5 | 2.2 | 0.4 | 0.342 |
| Phase 3 (22–42 days) | |||||
| NH3 | 11.9 | 10.6 | 12.4 | 0.2 | 0.038 |
| H2S | 4.1 | 3.2 | 4.3 | 1.0 | 0.046 |
| Acetaldehyde | 2.5 | 2.4 | 2.6 | 0.6 | 0.732 |
| CO2 | 1275 | 1375 | 1475 | 207 | 0.342 |
| Acetic acid | 2.3 | 2.1 | 1.5 | 0.5 | 0.669 |
| Propionic acid | 2.3 | 2.6 | 1.5 | 0.6 | 0.801 |
1 Abbreviation: Phase 1: TRT1, 6% BP; TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeast. Phase 3: TRT1; TRT2; TRT3, Basal diet (CON). 2 Standard error of means.
Effect of blood plasma and yeast supplementation on the fecal score of weaning pigs 1.
| Items | TRT1 1 | TRT2 1 | TRT3 1 | SEM 2 | |
|---|---|---|---|---|---|
| Fecal score 3 | |||||
| Initial | 3.55 | 3.53 | 3.51 | 0.03 | 0.548 |
| Phase 1 (0–7 days) | 3.51 | 3.46 | 3.48 | 0.03 | 0.281 |
| Phase 2 (8–21 days) | 3.36 | 3.32 | 3.34 | 0.04 | 0.133 |
| Phase 3 (22–42 days) | 3.26 | 3.24 | 3.21 | 0.05 | 0.816 |
1 Abbreviation: Phase 1: TRT1, 6% BP; TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeast. Phase 3: TRT1; TRT2; TRT3, Basal diet (CON). 2 Standard error of means. 3 Score: 1 = hard, dry pellets in a small, hard mass; 2 = hard, formed stool that remains firm and soft; 3 = soft, formed, and moist stool that retains its shape; 4 = soft, unformed stool that assumes the shape of the container; 5 = watery, liquid stool that can be poured.
Effect of blood plasma and yeast supplementation on the blood profile of weaning pigs 1.
| Items | TRT1 1 | TRT2 1 | TRT3 1 | SEM 2 | |
|---|---|---|---|---|---|
| Initial | |||||
| WBC, 103/μL | 13.90 | 14.02 | 15.82 | 1.99 | 0.903 |
| RBC, 106/μL | 6.31 | 6.22 | 6.27 | 0.31 | 0.750 |
| Lymphocyte, % | 42.0 | 42.5 | 41.6 | 2.5 | 0.463 |
| IgG, mg/dL | 137.0 | 136.3 | 142.8 | 24.5 | 0.501 |
| IgM, mg/dL | 59.0 | 60.5 | 62.3 | 14.2 | 0.661 |
| IgA, mg/dL | 36.3 | 32.5 | 39.8 | 3.9 | 0.440 |
| BUN, mg/dL | 4.3 | 4.5 | 4.5 | 1.2 | 0.336 |
| Creatinine, mg/dL | 0.67 | 0.69 | 0.70 | 0.05 | 0.132 |
| Phase 1 (0–7 days) | |||||
| WBC, 103/μL | 14.20 | 13.28 | 13.49 | 1.31 | 0.971 |
| RBC, 106/μL | 6.63 | 6.68 | 6.40 | 0.23 | 0.526 |
| Lymphocyte, % | 44.0 | 43.6 | 42.7 | 4.1 | 0.942 |
| IgG, mg/dL | 170.3 | 172.8 | 182.3 | 7.2 | 0.008 |
| IgM, mg/dL | 82.5 | 66.8 | 83.8 | 10.5 | 0.292 |
| IgA, mg/dL | 65.8 | 73.5 | 59.3 | 4.2 | 0.247 |
| BUN, mg/dL | 6.3 | 6.8 | 6.5 | 1.1 | 0.197 |
| Creatinine, mg/dL | 0.78 | 0.79 | 0.85 | 0.06 | 0.634 |
| Phase 2 (8–21 days) | |||||
| WBC, 103/μL | 15.36 | 17.28 | 18.64 | 1.32 | 0.128 |
| RBC, 106/μL | 6.91 | 6.64 | 6.20 | 0.27 | 0.305 |
| Lymphocyte, % | 44.3 | 43.1 | 45.3 | 5.2 | 0.961 |
| IgG, mg/dL | 272.5 | 293.8 | 297.5 | 36.7 | 0.747 |
| IgM, mg/dL | 81.8 | 79.3 | 74.3 | 11.3 | 0.957 |
| IgA, mg/dL | 145.0 | 127.8 | 137.3 | 9.4 | 0.758 |
| BUN, mg/dL | 10.0 | 9.3 | 9.5 | 1.8 | 0.842 |
| Creatinine, mg/dL | 1.09 | 0.93 | 1.05 | 0.08 | 0.642 |
| Phase 3 (22–42 days) | |||||
| WBC, 103/μL | 16.57 | 17.22 | 19.04 | 1.94 | 0.799 |
| RBC, 106/μL | 6.61 | 6.46 | 6.72 | 0.35 | 0.902 |
| Lymphocyte, % | 44.0 | 46.0 | 47.2 | 3.3 | 0.536 |
| IgG, mg/dL | 285.0 | 304.3 | 309.8 | 25.4 | 0.437 |
| IgM, mg/dL | 84.0 | 86.3 | 81.8 | 10.1 | 0.760 |
| IgA, mg/dL | 328.0 | 310.0 | 316.8 | 9.7 | 0.258 |
| BUN, mg/dL | 16.8 | 15.5 | 14.5 | 2.9 | 0.992 |
| Creatinine, mg/dL | 1.07 | 1.06 | 0.94 | 0.07 | 0.430 |
1 Abbreviation: Phase 1: TRT1, 6% BP; TRT2, 3% BP+ 3% yeast; TRT3, 6% yeast. Phase 2: TRT1, 3% BP; TRT2, 1.5% BP + 1.5% yeast; TRT3, 3% yeast. Phase 3: TRT1; TRT2; TRT3, Basal diet (CON). 2 Standard error of means.